N-[2-(dimethylamino)ethyl]-N-[(2-methyl-1H-imidazol-5-yl)methyl]-5-[(4-methylpiperidin-1-yl)methyl]furan-2-carboxamide
C21H33N5O2 — CID 135096890
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-(dimethylamino)ethyl]-N-[(2-methyl-1H-imidazol-5-yl)methyl]-5-[(4-methylpiperidin-1-yl)methyl]furan-2-carboxamide
N-[2-(dimethylamino)ethyl]-N-[(2-methyl-1H-imidazol-5-yl)methyl]-5-[(4-methylpiperidin-1-yl)methyl]furan-2-carboxamide (PubChem CID 135096890) has the molecular formula C21H33N5O2 and a molecular weight of 387.53 g/mol. Its IUPAC name is N-[2-(dimethylamino)ethyl]-N-[(2-methyl-1H-imidazol-5-yl)methyl]-5-[(4-methylpiperidin-1-yl)methyl]furan-2-carboxamide.
Molecular Properties
| Compound Name | N-[2-(dimethylamino)ethyl]-N-[(2-methyl-1H-imidazol-5-yl)methyl]-5-[(4-methylpiperidin-1-yl)methyl]furan-2-carboxamide |
|---|---|
| PubChem CID | 135096890 |
| Molecular Formula | C21H33N5O2 |
| Molecular Weight | 387.53 g/mol |
| Exact Mass | 387.26 |
| IUPAC Name | N-[2-(dimethylamino)ethyl]-N-[(2-methyl-1H-imidazol-5-yl)methyl]-5-[(4-methylpiperidin-1-yl)methyl]furan-2-carboxamide |
| SMILES | Cc1ncc(CN(CCN(C)C)C(=O)c2ccc(CN3CCC(C)CC3)o2)[nH]1 |
| InChI | InChI=1S/C21H33N5O2/c1-16-7-9-25(10-8-16)15-19-5-6-20(28-19)21(27)26(12-11-24(3)4)14-18-13-22-17(2)23-18/h5-6,13,16H,7-12,14-15H2,1-4H3,(H,22,23) |
| InChIKey | QATSCQFZTLMMGN-UHFFFAOYSA-N |
| XLogP | 2.75 |
| TPSA | 68.61 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 387.53 |
| LogP ≤ 5 | 2.75 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135096890 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.